Fortress Biotech (FBIO) Depreciation & Amortization (CF) (2014 - 2017)
Fortress Biotech (FBIO) posted quarterly Depreciation & Amortization (CF) of $103000.0 for Q4 2025, down 26.43% year-over-year from $140000.0 in Q4 2024, and up 3.0% quarter-over-quarter from $100000.0 in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Depreciation & Amortization (CF) (2014 - 2017) Analysis & Trends
Fortress Biotech's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $103000.0 for Q4 2025.
- In Q4 2025, Depreciation & Amortization (CF) fell 26.43% year-over-year to $103000.0; the TTM figure through Dec 2025 stood at $429000.0 (down 57.82% YoY), while the FY2025 annual figure was $403000.0, down 61.25% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $103000.0, up from $100000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $844000.0 in Q1 2023, with the low at $100000.0 in Q3 2024.
- The 5-year median for Depreciation & Amortization (CF) is $500000.0 (2021), against an average of $476250.0.
- The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) soared 33.33% in 2022, then plunged 75.0% in 2024.
- Fortress Biotech's Depreciation & Amortization (CF) stood at $732000.0 in 2021, then gained by 9.29% to $800000.0 in 2022, then slumped by 62.5% to $300000.0 in 2023, then sank by 53.33% to $140000.0 in 2024, then decreased by 26.43% to $103000.0 in 2025.
- Business Quant data shows FBIO's Depreciation & Amortization (CF) at $103000.0 in Q4 2025, $100000.0 in Q3 2025, and $100000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 682,000.00 |
| Dec 31, 2016 | 704,000.00 |
| Sep 30, 2016 | 166,000.00 |
| Jun 30, 2016 | 70,000.00 |
| Mar 31, 2016 | 4,000.00 |
| Dec 31, 2015 | 9,000.00 |
| Sep 30, 2015 | 6,000.00 |
| Jun 30, 2015 | 5,000.00 |
| Mar 31, 2015 | 6,000.00 |
| Dec 31, 2014 | 6,000.00 |
| Sep 30, 2014 | 6,000.00 |